Focus Taiwan App
Download

List of qualifying conditions for COVID-19 drugs expanded

04/23/2022 10:25 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's Central Epidemic Command Center (CECC) has expanded its list of pre-existing conditions that qualify individuals as "high risk" of severe COVID-19 and thus eligible to receive oral treatments such as Molnupiravir and Paxlovid.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.75